Skip to Main Content
Skip Nav Destination






(e ver OH li mus)

Brand Names: US

  • Afinitor
  • Afinitor Disperz
  • Zortress

Therapeutic Category

  • Antineoplastic Agent, mTOR Kinase Inhibitor
  • Immunosuppressant Agent

Medication Safety Issues

Sound-alike/look-alike issues:

Everolimus may be confused with sirolimus (conventional), sirolimus (protein bound), tacrolimus, temsirolimus

Afinitor may be confused with afatinib

High alert medication:

This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.

Administration issues:

Tablets (Afinitor, Zortress) and tablets for oral suspension (Afinitor Disperz) are not interchangeable; do not combine formulations to achieve total desired dose.

This item requires a subscription. For full access to this content, please log in to an existing user account or purchase an individual subscription. If you have an active subscription and appear logged in (your name appears in the upper right corner), but you cannot access content, please click the “Log Out” option under your name and log back in.
Close Modal

or Create an Account

Close Modal
Close Modal